Assignee
SAHIN UGUR
DE·28 granted patents·11 pending applications·383 citations·filing 2006–2016
Top patents by PatentIndex Score
39 records- 0195US8946388B2Monoclonal antibodies for treatment of cancerSAHIN UGUR·Filed 2009·Granted Feb 3, 2015·41 cites·16 claims
- 0295US8425902B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2008·Granted Apr 23, 2013·20 cites·3 claims
- 0395US8168427B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2006·Granted May 1, 2012·47 cites·5 claims
- 0494US10738355B2Individualized vaccines for cancerSAHIN UGUR·Filed 2012·Granted Aug 11, 2020·41 cites·25 claims
- 0594US10117918B2Antigen-specific T cell receptors and T cell epitopesSAHIN UGUR·Filed 2016·Granted Nov 6, 2018·18 cites·13 claims
- 0694US9476055B2Modification of RNA, producing an increased transcript stability and translation efficiencySAHIN UGUR·Filed 2006·Granted Oct 25, 2016·29 cites·19 claims
- 0794US8637012B2Genetic products differentially expressed in tumors and the use thereofSAHIN UGUR·Filed 2011·Granted Jan 28, 2014·18 cites·9 claims
- 0894US8586047B2Genetic products differentially expressed in tumors and the use thereofSAHIN UGUR·Filed 2009·Granted Nov 19, 2013·20 cites·18 claims
- 0994US8088588B2Genetic products differentially expressed in tumors and the use of thereofSAHIN UGUR·Filed 2008·Granted Jan 3, 2012·17 cites·13 claims
- 1093US9718886B2Cancer therapy using CLDN6 target-directed antibodies in vivoSAHIN UGUR·Filed 2011·Granted Aug 1, 2017·13 cites·6 claims
- 1192US9487584B2Antibodies specific for claudin 6 (CLDN6)SAHIN UGUR·Filed 2010·Granted Nov 8, 2016·19 cites·20 claims
- 1292US9321842B2Antibodies for treatment of cancerSAHIN UGUR·Filed 2012·Granted Apr 26, 2016·14 cites·30 claims
- 1392US9295717B2Vaccine composition comprising 5′-cap modified RNASAHIN UGUR·Filed 2010·Granted Mar 29, 2016·18 cites·16 claims
- 1491US9175088B2Identification of tumor-associated markers for diagnosing or monitoring ovarian cancerSAHIN UGUR·Filed 2010·Granted Nov 3, 2015·8 cites·14 claims
- 1589US9212228B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2012·Granted Dec 15, 2015·9 cites·42 claims
- 1687US9486519B2Use of FLT3 ligand for enhancing immune responses in RNA immunizationSAHIN UGUR·Filed 2009·Granted Nov 8, 2016·15 cites·6 claims
- 1786US9216218B2Monoclonal antibodies for treatment of cancerSAHIN UGUR·Filed 2011·Granted Dec 22, 2015·11 cites·6 claims
- 1886US9090940B2Identification of surface-associated antigens for tumor diagnosis and therapySAHIN UGUR·Filed 2006·Granted Jul 28, 2015·3 cites·11 claims
- 1985US9499609B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2011·Granted Nov 22, 2016·5 cites·21 claims
- 2085US8975375B2Identification of tumor-associated antigens for diagnosis and therapySAHIN UGUR·Filed 2011·Granted Mar 10, 2015·5 cites·15 claims
- 2184US9586997B2Antigen-specific T cell receptors and T cell epitopesSAHIN UGUR·Filed 2011·Granted Mar 7, 2017·6 cites·12 claims
- 2280US8945923B2Antigen-specific clonal expansion of B cellsSAHIN UGUR·Filed 2010·Granted Feb 3, 2015·4 cites·8 claims
- 2377US9637548B2Methods and compositions for diagnosis and treatment of cancerSAHIN UGUR·Filed 2010·Granted May 2, 2017·2 cites·5 claims
- 2468US8716455B2Genetic products differentially expressed in tumors and use thereofSAHIN UGUR·Filed 2008·Granted May 6, 2014·0 cites·15 claims
- 2565US2014134165A1Identification of Tumor-Associated Markers for Diagnosis and TherapySAHIN UGUR·Filed 2014·Application pending·0 cites
- 2664US2009253775A1Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer MetastasisSAHIN UGUR·Filed 2009·Application pending·0 cites
- 2764US2011065103A1Use of rna for reprogramming somatic cellsSAHIN UGUR·Filed 2008·Application pending·0 cites
- 2864US2014186338A1Genetic Products Differentially Expressed In Tumors And The Use ThereofSAHIN UGUR·Filed 2013·Application pending·0 cites
- 2961US8551490B2Genetic products differentially expressed in tumors and use thereofSAHIN UGUR·Filed 2011·Granted Oct 8, 2013·0 cites·25 claims
- 3061US2014017254A1Identification of Tumor-Associated Antigens for Diagnosis and TherapySAHIN UGUR·Filed 2013·Application pending·0 cites
- 3161US2009202530A1Identification of Tumor-Associated Antigens for Diagnosis and TherapySAHIN UGUR·Filed 2006·Application pending·0 cites
- 3259US8088913B2Compositions and methods for therapy and diagnosis of cancerSAHIN UGUR·Filed 2006·Granted Jan 3, 2012·0 cites·21 claims
- 3359US2015337052A1Genetic Products Differentially Expressed In Tumors And The Use ThereofSAHIN UGUR·Filed 2015·Application pending·0 cites
- 3452US8399210B2Autoantigenes for improved diagnosis, prognosis and treatment of inflammatory neurological diseasesSAHIN UGUR·Filed 2009·Granted Mar 19, 2013·0 cites·9 claims
- 3552US2011027297A1Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and TestingSAHIN UGUR·Filed 2009·Application pending·0 cites
- 3650US9809815B2Methods and compositions for diagnosis and treatment of cancerSAHIN UGUR·Filed 2010·Granted Nov 7, 2017·0 cites·13 claims
- 3748US2012165390A1Compositions and Methods for Therapy and Diagnosis of CancerSAHIN UGUR·Filed 2011·Application pending·0 cites
- 3844US2012070430A1Identification of tumor-associated markers for diagnosis and therapySAHIN UGUR·Filed 2010·Application pending·0 cites
- 3938US2014030808A1Method for Cellular RNA ExpressionSAHIN UGUR·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →